PT - JOURNAL ARTICLE AU - van der Lee, Lisa AU - Regli, Adrian AU - Allen, Christopher AU - Anstey, Matthew AU - Blakeman, Robert AU - Denehy, Linda AU - Dennis, Diane AU - Elliott, Mercedes AU - Hill, Anne-Marie AU - Ho, Kwok-Ming AU - Jacob, Wendy AU - Jacques M, Angela AU - Marsh, Lisa AU - Palermo, Mark AU - Wibrow, Bradley AU - Ntoumenopoulos, George TI - An implementation-effectiveness trial investigating feasibility, safety and efficacy of Best pRacticE guideline cAre physioTHErapy with addition of protocolised ventilator hyperinflation on patient-important outcomes for critically ill adults intUbated and ventilated with Pneumonia. (BREATHE UP) AID - 10.1101/2024.11.10.24317069 DP - 2024 Jan 01 TA - medRxiv PG - 2024.11.10.24317069 4099 - http://medrxiv.org/content/early/2024/11/11/2024.11.10.24317069.short 4100 - http://medrxiv.org/content/early/2024/11/11/2024.11.10.24317069.full AB - Pneumonia is a common cause for intensive care unit (ICU) admission for breathing support from a mechanical ventilator, resulting in high morbidity, mortality, and healthcare costs. Physiotherapists working in ICU treat patients with critical pneumonia using a range of respiratory treatments to improve breathing, hasten weaning from the ventilator, and restore functional independence. Evidence supports the short-term benefits of these treatments, however currently no standard of physiotherapy practice exists for these ICU patients. Despite a plethora of studies which have shown that physiotherapy treatments, such as ventilator lung hyperinflation (VHI), aid the lungs to work better short-term, there are no studies to date which investigate the effect of these important treatments on meaningful patient-important outcomes, such as earlier weaning from the ventilator, earlier hospital discharge, less breathlessness and lung secretions, short- and longer-term disability, health- related quality of life and survival. Through previous multiphase mixed-methods research, a clinical practice guideline was developed outlining best physiotherapy practice for this ICU patient cohort. This proposed research involves conducting a multicentre hybrid implementation-effectiveness randomised, controlled trial which aims to: evaluate implementation of physiotherapy guideline care for management of pneumonia in ICU regarding feasibility, safety and acceptability; and to determine the safety and effectiveness of a standardised dosage of daily ventilator hyperinflation in addition to standard guideline care on patient-important outcomes, health system outcomes; and cost effectiveness. This study will address critical knowledge gaps in the ICU physiotherapy evidence base regarding the impact of a course of standardised, best practice respiratory physiotherapy intervention during the ICU stay for patients with critical pneumonia requiring invasive mechanical ventilation, provide valuable information for clinicians to inform clinical practice regarding treatable traits and streamlining care to promote clinical efficiency, and determine the impact of respiratory physiotherapy care on patient-important and health service outcomes.Trial registration ANZ Clinical trials Registry number ACTRN12624001130550.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialACTRN12624001130550Funding StatementThe Coordinating Principal Investigator, Dr Lisa van der Lee, is supported to conduct this study through the award of a Raine Clinician Research Fellowship from the Raine Medical Research Foundation. Prof Anne-Marie Hill is supported by a NHMRC Investigator grant (EL1) and the Royal Perth Hospital Research Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics approval was granted from the South Metropolitan Health Service Human Research Ethics Committee on 24/07/2024. Reference number RGS6734.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThis is a protocol paper, there is no data available at present.